Cohen, A.; Sah, J.; Lee, T.; Rosenblatt, L.; Hlavacek, P.; Emir, B.; Keshishian, A.; Yuce, H.; Luo, X.
Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity. J. Clin. Med. 2021, 10, 200.
https://doi.org/10.3390/jcm10020200
AMA Style
Cohen A, Sah J, Lee T, Rosenblatt L, Hlavacek P, Emir B, Keshishian A, Yuce H, Luo X.
Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity. Journal of Clinical Medicine. 2021; 10(2):200.
https://doi.org/10.3390/jcm10020200
Chicago/Turabian Style
Cohen, Alexander, Janvi Sah, Theodore Lee, Lisa Rosenblatt, Patrick Hlavacek, Birol Emir, Allison Keshishian, Huseyin Yuce, and Xuemei Luo.
2021. "Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity" Journal of Clinical Medicine 10, no. 2: 200.
https://doi.org/10.3390/jcm10020200
APA Style
Cohen, A., Sah, J., Lee, T., Rosenblatt, L., Hlavacek, P., Emir, B., Keshishian, A., Yuce, H., & Luo, X.
(2021). Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity. Journal of Clinical Medicine, 10(2), 200.
https://doi.org/10.3390/jcm10020200